Lecture
Börsengang und Börsennotiz – die unterschätzte Finanzierungsoption?
- at -
- A3.527Biotech Finance Day
- Type: Discussion
Lecture description
Kurze Impulse plus Panel-Diskussion
Participant
- Dr. Rainer Strohmenger
- Country
- Germany
- Job Title
- Managing Partner
- Company
- Wellington Partners
- Dr. Daniel Vitt
- Country
- Germany
- Job Title
- CEO
- Company
- Immunic AG
- Caroline von Linsingen
- Country
- Germany
- Job Title
- Head of IPO and Growth Financing
- Company
- Deutsche Börse
- Magnus Olsson
- Country
- Germany
- Job Title
- Head of ECM
- Company
- Nasdaq Stockholm
